Zimbabwe has turned down a substantial US health deal valued at 367 million US dollars (£272m) spanning five years due to Washington's demand for sensitive biological samples.
This move became public following a government memo dated December was disclosed, which showed President Emmerson Mnangagwa believed the agreement was "unbalanced".
An official representative has since explained that the United States was demanding access to biological samples for research and profit while refused to share the benefits from any future treatments.
"We must now begin the challenging and unfortunate process of winding down our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the United States had donated over $1.9bn as health assistance to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has urged more negotiations to reach a deal agreeable to all parties so the nation's vital HIV programme can continue.
Wider Background
This development follows a comparable case in Kenya, where a court halted a similar deal with the US after legal challenges were filed about the safety of citizens' health data.
Since returning to office last year, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.
The agency had managed assistance for the US government, but Trump stated its spending was "inefficient" and his administration was pursuing direct bilateral agreements to boost transparency and accountability.
Based on reports, Sixteen nations in Africa have to date agreed to similar agreements, representing more than $18.3bn of fresh investment.
Details of the Rejected Agreement
The money for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this collaboration might have yielded extraordinary benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently on HIV treatment through American-funded initiatives," the Ambassador said.
However, official spokesman Nick Mangwana argued the arrangement was "asymmetrical".
"The proposal required Zimbabwe to share its genetic material and health information for a long time, with no corresponding assurance of access to any medical innovations – like vaccines, diagnostics, or treatments – that might result from that shared data," his statement read.
"Effectively, our nation would supply the basic resources for medical research without any certainty that the resulting innovations would be accessible to our citizens should a future disease outbreak emerge."
National Interest and Global Health
He also pointed out that the American exit from the global health body and its pursuit of one-on-one deals were undermining structures previously established through the international health agency.
Mangwana cited its Pathogen Access and Benefit Sharing framework designed to deal with future global health emergencies.
"This mechanism is intended to ensure that when a country contributes its information, the resulting advantages – including medicines and cures – are shared equitably, not commercialised solely by those with the funds to develop them."
The government's concerns regarding the US deal "are not meant as anti-American sentiment," he added.
"We are open to further dialogue with our US partners on how subsequent co-operation might be arranged in a manner that honours the independence and interests of each country."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the official position, but recommended that talks should continue given that a large portion of the country's HIV programmes depended on foreign aid.
"In cases where specific concerns arise, including those involving data governance or implementation frameworks, these can frequently be addressed through detailed discussion and mutually agreed protections," the group commented.
This impasse emphasises the continuing tensions between receiving crucial foreign assistance and protecting a country's data in an ever more interconnected world.